Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Kurze Gold-Preis-Konsolidierung zum Einstieg in diese Aktie nutzen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
220 Leser
Artikel bewerten:
(1)

Yuyu Pharma Publishes History for 80th Anniversary

The history of Yuyu's challenges and changes during the past 80 years as a first-generation pharmaceutical company will be composed in storytelling format

SEOUL, South Korea, March 3, 2021 /PRNewswire/ -- Yuyu Pharma (KRX: 000220, CEO Robert Wonsang Yu), in anticipation of the 80th anniversary of its establishment on February 28th, 2021, published its history of challenges and changes over the past 80 years. The history is told in storytelling format centered around a series of interviews with the people who have shared this history.

Yuyu Pharma Publishes History for 80th Anniversary

The 80th anniversary history was organized based on visual data giving a glimpse of that time period, such as Yuyu's product advertisements during the 1940's and 50's, product instruction manuals from the 1960's, and interviews with former and current employees.

The history consists of three chapters. Chapter 1 summarizes the major issues Yuyu faced during each 20-year period since its establishment in 1941. Chapter 2 consists of Q&A sessions with Chairman Seungpil Yu and CEO Wonsang Yu; interviews with 9 employees who have worked at Yuyu for at least 20 years such as factory director, union chairman, salespeople, and custodians; and one-sentence descriptions of Yuyu Pharma by new employees.

The 80th anniversary history of Yuyu Pharma consists of 236 total pages. It will also be published in e-book pdf file format and will be available on Yuyu Pharma's website.

About Yuyu Pharma

Yuyu Pharma (KRX: 000220) is a Korean pharmaceutical company founded in 1941 and listed on the Korean Stock Exchange since 1975. The company manufactures and distributes pharmaceutical products, medical devices, and food supplements. Yuyu Pharma is also committed to developing innovative therapeutics in the area of Ophthalmology, Urology, and Neurology.

Media Contact
Sean Yoon, hjyoon@yuyu.co.kr

Logo

Photo - https://mma.prnewswire.com/media/1448515/Yuyu_History.jpg
Logo - https://mma.prnewswire.com/media/1392726/Yuyu_Pharma_Logo.jpg

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2021 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.